Inclusion of JNK-independent drugs within multi-agent chemotherapy improves response in relapsed high-risk neuroblastoma
Jeremy Z. R. Han, Monica Phimmachanh, Jordan F. Hastings, King Ho Leong, Boaz H. Ng, Jing Ni, Angela Fontaine-Titley, Antonia L. Cadell, Yolande E. I. O’Donnell, Misaki S. Clearwater, Alvin Kamili, Michelle Haber, Murray D. Norris, Paul Timpson, Toby N. Trahair, , David R. Croucher
The paper identifies JNK-independent drugs that, when combined with standard chemotherapy, improve response in relapsed high-risk neuroblastoma by exploiting differential apoptotic network utilization.
Science Advances · Nov 28, 2025Peer-reviewedCancer Biology